|
Following are some of the Cancer types where Curcumin - Turmeric is shown to have positive impact. Colon Cancer: Curcumin inhibited chemically induced carcinogenesis in the colon when administered at different stages of the cancer process. Laboratory rats, administered curcumin during either initiation or late in the premalignant phase, had a lesser incidence and fewer numbers of invasive malignant colon tumors (Kawamori et al. 1999). Also, by inhibiting COX-2-arachidonic acid interactions, curcumin suppresses prostaglandins responsible for inflammatory processes (Plummer et al. 1999). Chronic inflammation has for decades been regarded as a cause of colon cancer (Konig et al. 1976). Breast cancer: Curcumin inhibits the growth of multiple breast cancer cell lines (Inano et al. 1999), particularly those that result from exposure to environmental estrogens such as chemicals and pesticides (Verma et al. 1998). Also, curcumin, estrogen, and estrogen mimickers gain entry into the cell through the aryl hydrocarbon receptor. Because curcumin competes for entry, it can crowd out damaging materials (Ciolino et al. 1998). According to researchers, curcumin blends well with other cancer inhibitors. For example, a curcumin-isoflavonoid combination suppressed the growth of estrogen receptor-positive cancer cells up to 95% (Verma et al. 1998). Skin Cancer: Curcumin inhibits skin tumors. When applied topically, curcumin reduces skin inflammation and inhibits local swelling (Huang et al. 1997). Prostate cancer: Curcumin was able to decrease the proliferative potential of androgen-independent prostate cancer cells--and cells of other androgen-dependent cancers--largely by encouraging apoptosis. Moreover, a significant decrease in microvessel density, the sustaining blood supply of a tumor, was also observed (Dorai et al. 2001). Leukemia: Curcumin-induced
apoptotic cell death in promyelocytic leukemia HL-60 cells at
concentrations as low as 3.5 mcg/mL (Kuo et al. 1996). Protein kinase C
(PKC) and epidermal growth factors (EGF): Curcumin was proclaimed "potentially
useful" in developing anti-proliferative strategies to control tumor growth
by suppressing the activity of protein kinase C (PKC) (Korutla et al. 1995).
As the activity of PKC is slowed down, tumor proliferation is halted (Lin
et al. 1997). PKC transmits signals from the epidermal growth factor receptor
(EGF-R), a cycle that ultimately encourages the growth of tumors. Conversely,
cancers awaiting EGF stimulation are dealt a severe blow if this pathway
is severed. Curcumin blocked the activation of EGF by 90%.
Order - Turmeric Hills
All commercial transactions
done through
Please use the form below to mail us for any information. We will revert back within 8 hours. EMF
PHP
Forms
|